204 related articles for article (PubMed ID: 30584280)
1. SREBP-2, a new target of metformin?
Zhang F; Sun W; Chen J; Jiang L; Yang P; Huang Y; Gong A; Liu S; Ma S
Drug Des Devel Ther; 2018; 12():4163-4170. PubMed ID: 30584280
[TBL] [Abstract][Full Text] [Related]
2. Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway.
Li X; Hu X; Pan T; Dong L; Ding L; Wang Z; Song R; Wang X; Wang N; Zhang Y; Wang J; Yang B
Biomed Pharmacother; 2021 Jan; 133():110802. PubMed ID: 33202286
[TBL] [Abstract][Full Text] [Related]
3. Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice.
Lee JH; Jia Y; Thach TT; Han Y; Kim B; Wu C; Kim Y; Seo WD; Lee SJ
Nutr Res; 2017 Jul; 43():89-99. PubMed ID: 28676202
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins.
Yashiro T; Nanmoku M; Shimizu M; Inoue J; Sato R
Atherosclerosis; 2012 Feb; 220(2):369-74. PubMed ID: 22153697
[TBL] [Abstract][Full Text] [Related]
5. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.
Li Y; Xu S; Mihaylova MM; Zheng B; Hou X; Jiang B; Park O; Luo Z; Lefai E; Shyy JY; Gao B; Wierzbicki M; Verbeuren TJ; Shaw RJ; Cohen RA; Zang M
Cell Metab; 2011 Apr; 13(4):376-388. PubMed ID: 21459323
[TBL] [Abstract][Full Text] [Related]
6. Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells.
Lee KS; Kwon YS; Kim S; Moon DS; Kim HJ; Nam KS
Biomed Pharmacother; 2017 Feb; 86():405-413. PubMed ID: 28012395
[TBL] [Abstract][Full Text] [Related]
7. MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent.
Bjune K; Sundvold H; Leren TP; Naderi S
Atherosclerosis; 2018 Sep; 276():28-38. PubMed ID: 30025252
[TBL] [Abstract][Full Text] [Related]
8. Unripe
Lee KH; Jeong ES; Jang G; Na JR; Park S; Kang WS; Kim E; Choi H; Kim JS; Kim S
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110925
[TBL] [Abstract][Full Text] [Related]
9. Polydatin Improves Glucose and Lipid Metabolisms in Insulin-Resistant HepG2 Cells through the AMPK Pathway.
Hao J; Huang K; Chen C; Liang Y; Wang Y; Zhang X; Huang H
Biol Pharm Bull; 2018; 41(6):891-898. PubMed ID: 29863077
[TBL] [Abstract][Full Text] [Related]
10. Activated AMPK explains hypolipidemic effects of sulfated low molecular weight guluronate on HepG2 cells.
Liu X; Hao JJ; Zhang LJ; Zhao X; He XX; Li MM; Zhao XL; Wu JD; Qiu PJ; Yu GL
Eur J Med Chem; 2014 Oct; 85():304-10. PubMed ID: 25089813
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
12. Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression.
Zhu X; Yan H; Xia M; Chang X; Xu X; Wang L; Sun X; Lu Y; Bian H; Li X; Gao X
Lipids Health Dis; 2018 May; 17(1):114. PubMed ID: 29759071
[TBL] [Abstract][Full Text] [Related]
13. Role of AMP-activated protein kinase in mechanism of metformin action.
Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
[TBL] [Abstract][Full Text] [Related]
14. Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis.
Gopoju R; Panangipalli S; Kotamraju S
Free Radic Biol Med; 2018 Apr; 118():85-97. PubMed ID: 29499335
[TBL] [Abstract][Full Text] [Related]
15. AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.
Liu S; Jing F; Yu C; Gao L; Qin Y; Zhao J
PLoS One; 2015; 10(5):e0124951. PubMed ID: 25933205
[TBL] [Abstract][Full Text] [Related]
16. Metformin attenuates palmitic acid-induced insulin resistance in L6 cells through the AMP-activated protein kinase/sterol regulatory element-binding protein-1c pathway.
Wu W; Tang S; Shi J; Yin W; Cao S; Bu R; Zhu D; Bi Y
Int J Mol Med; 2015 Jun; 35(6):1734-40. PubMed ID: 25891779
[TBL] [Abstract][Full Text] [Related]
17. An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes.
Zhang L; McCabe T; Condra JH; Ni YG; Peterson LB; Wang W; Strack AM; Wang F; Pandit S; Hammond H; Wood D; Lewis D; Rosa R; Mendoza V; Cumiskey AM; Johns DG; Hansen BC; Shen X; Geoghagen N; Jensen K; Zhu L; Wietecha K; Wisniewski D; Huang L; Zhao JZ; Ernst R; Hampton R; Haytko P; Ansbro F; Chilewski S; Chin J; Mitnaul LJ; Pellacani A; Sparrow CP; An Z; Strohl W; Hubbard B; Plump AS; Blom D; Sitlani A
Int J Biol Sci; 2012; 8(3):310-27. PubMed ID: 22355267
[TBL] [Abstract][Full Text] [Related]
18. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells.
Yang J; Craddock L; Hong S; Liu ZM
J Cell Biochem; 2009 Feb; 106(3):414-26. PubMed ID: 19125418
[TBL] [Abstract][Full Text] [Related]
19. Effect of Genistein on Cholesterol Metabolism-Related Genes in HepG2 Cell.
Lu R; Zheng Z; Yin Y; Jiang Z
J Food Sci; 2019 Aug; 84(8):2330-2336. PubMed ID: 31313321
[TBL] [Abstract][Full Text] [Related]
20. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
